SANGAMO THERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $980.40 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $980.40M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $818.50M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $764.60M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $689.70M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2025-12-31 | $980.40M 10-K · filed 2026-03-30 |
| 2024-12-31 | $818.50M 10-K · filed 2025-03-17 |
| 2023-12-31 | $764.60M 10-K · filed 2024-03-13 |
| 2022-12-31 | $689.70M 10-K · filed 2023-02-23 |
| 2021-12-31 | $605.60M 10-K · filed 2022-02-24 |
| 2020-12-31 | $622.60M 10-K · filed 2021-02-24 |
| 2019-12-31 | $489.40M 10-K · filed 2020-02-28 |
| 2018-12-31 | $535.00M 10-K · filed 2019-03-01 |
| 2017-12-31 | $475.00M 10-K · filed 2018-03-01 |
| 2016-12-31 | $412.00M 10-K · filed 2017-02-28 |
| 2015-12-31 | $351.30M 10-K · filed 2016-02-18 |
| 2014-12-31 | $330.90M 10-K · filed 2015-02-25 |
| 2013-12-31 | $209.00M 10-K · filed 2014-02-24 |
| 2012-12-31 | $187.10M 10-K · filed 2013-02-26 |